chartexchange
EDTUTC-4 New York
Sign up
FeedbackDocs

IBRX270115P00016000
IBRX Jan 15 2027 16.00 Put
optionOPRA

EODOct 16, 2026
6.94USD+1.611%(+0.11)5Vol346OI
Loading…
Underlying
IBRX
Underlying Price
$8.48
Type
Put
Strike
16
Expiration
Jan 15, 2027
DTE
87d
Moneyness
ITM
Intrinsic
$7.52
IBRX 16 Put Across Expirations
ExpirationDTELastChangeVolOpen Int
Oct 23, 20263d——00
Oct 30, 202610d$7.54+0.00%63
Nov 6, 202617d$6.32+3.44%31
Nov 13, 202624d——00
Nov 20, 202631d——00
Nov 27, 202638d——00
Dec 18, 202659d——00
Jan 15, 202787d$6.94+1.61%5346
Mar 19, 2027150d——00
Apr 16, 2027178d——00
May 21, 2027213d——00
IBRX Nearby Strikes · Jan 15, 2027
StrikeLastChangeVolOpen IntMoneyness
10 P$2.06+1.48%506,506ITM
11 P$2.65-7.02%7150ITM
12 P$3.30-10.81%4881ITM
13 P$4.70+14.63%26ITM
14 P$4.80-9.60%2024ITM
15 P$7.70+21.84%1503ITM
16 P$6.94+1.61%5346ITM
17 P$7.75+2.24%5692ITM
18 P$8.75+3.06%818ITM
20 P$11.40-13.64%2023ITM
22 P$11.97-9.32%3143ITM
IBRX Profile

immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.